Irreversible Electroporation for Prostate Tissue Ablation in Patients with Intermediate-risk Prostate Cancer: Results from the PRESERVE Trial.
Irreversible Electroporation for Prostate Tissue Ablation in Patients with Intermediate-risk Prostate Cancer: Results from the PRESERVE Trial. Eur Urol. 2026 Jan; 89(1):57-68.
PMID: 40685282
Bevacizumab and Erlotinib in Hereditary and Sporadic Papillary Kidney Cancer.
Bevacizumab and Erlotinib in Hereditary and Sporadic Papillary Kidney Cancer. N Engl J Med. 2025 Jun 19; 392(23):2346-2356.
PMID: 40532152
A Prospective Study of Stereotactic Body Radiation Therapy in Oligometastatic Renal Cell Carcinoma.
A Prospective Study of Stereotactic Body Radiation Therapy in Oligometastatic Renal Cell Carcinoma. Int J Radiat Oncol Biol Phys. 2025 May 30.
PMID: 40451439
Post-Treatment Imaging in Focal Therapy: Understanding TARGET and PI-FAB Scoring Systems.
Post-Treatment Imaging in Focal Therapy: Understanding TARGET and PI-FAB Scoring Systems. Diagnostics (Basel). 2025 May 26; 15(11).
PMID: 40506900
Surveillance After Focal Therapy for Prostate Cancer: A Comprehensive Review.
Surveillance After Focal Therapy for Prostate Cancer: A Comprehensive Review. Cancers (Basel). 2025 Apr 16; 17(8).
PMID: 40282513
Prebiopsy Magnetic Resonance Imaging Followed by Combination Biopsy for Prostate Cancer Diagnosis Is Associated with a Lower Risk of Biochemical Failure After Treatment Compared to Systematic Biopsy Alone.
Prebiopsy Magnetic Resonance Imaging Followed by Combination Biopsy for Prostate Cancer Diagnosis Is Associated with a Lower Risk of Biochemical Failure After Treatment Compared to Systematic Biopsy Alone. Diagnostics (Basel). 2025 Mar 12; 15(6).
PMID: 40150041
Outcomes of Salvage Radical Prostatectomy after Focal Therapy.
Outcomes of Salvage Radical Prostatectomy after Focal Therapy. World J Urol. 2025 Feb 06; 43(1):106.
PMID: 39912914
Re: Guillaume Ploussard, Patrick Coloby, Thierry Chevallier, et al. Whole-gland or Subtotal High-intensity Focused Ultrasound Versus Radical Prostatectomy: The Prospective, Noninferiority, Nonrandomized HIFI Trial. Eur Urol. 2025;87:526-533.
Re: Guillaume Ploussard, Patrick Coloby, Thierry Chevallier, et al. Whole-gland or Subtotal High-intensity Focused Ultrasound Versus Radical Prostatectomy: The Prospective, Noninferiority, Nonrandomized HIFI Trial. Eur Urol. 2025;87:526-533. Eur Urol. 2025 May; 87(5):e89-e90.
PMID: 39863507
Shifting tides: A survey analysis of urologists' evolving attitudes toward focal therapy for prostate cancer.
Shifting tides: A survey analysis of urologists' evolving attitudes toward focal therapy for prostate cancer. Indian J Urol. 2025 Jan-Mar; 41(1):59-65.
PMID: 39886635
Prostate ablation for the management of localized prostate cancer.
Prostate ablation for the management of localized prostate cancer. Urol Oncol. 2025 03; 43(3):194.e9-194.e17.
PMID: 39592359